VYNE Therapeutics Inc
(NASDAQ:VYNE)
$3.39
0.08[2.42%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$3.39
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open3.500Close3.470
Vol / Avg.35.656K / 351.189KMkt Cap47.315M
Day Range3.341 - 3.60052 Wk Range2.034 - 8.730

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open3.500Close3.470
Vol / Avg.35.656K / 351.189KMkt Cap47.315M
Day Range3.341 - 3.60052 Wk Range2.034 - 8.730
Lisa Levin - Oct 30, 2023, 3:06PM
Lisa Levin - Oct 30, 2023, 1:55PM
Vandana Singh - Oct 30, 2023, 1:29PM
Lisa Levin - Oct 30, 2023, 12:14PM
Erica Kollmann - Oct 30, 2023, 10:19AM
Lisa Levin - Oct 30, 2023, 9:46AM
Lisa Levin - May 12, 2023, 1:09PM
Lisa Levin - Apr 19, 2023, 2:33PM
Lisa Levin - Apr 19, 2023, 1:04PM
Vandana Singh - Apr 19, 2023, 11:26AM
Globe Newswire - Nov 13, 2023, 7:45AM
Globe Newswire - Nov 7, 2023, 8:00AM
Globe Newswire - Nov 1, 2023, 4:15PM
Globe Newswire - Oct 30, 2023, 7:20AM
Globe Newswire - Oct 30, 2023, 7:05AM
Globe Newswire - Oct 30, 2023, 7:00AM
Globe Newswire - Sep 6, 2023, 8:00AM
Globe Newswire - Aug 14, 2023, 8:00AM
Globe Newswire - May 18, 2023, 8:00AM
Globe Newswire - May 11, 2023, 4:01PM
Full archive of press releases available on Benzinga Pro
Seeking Alpha - Nov 20, 2023, 11:51AM
Seeking Alpha - Nov 13, 2023, 5:18PM
InvestorsObserver - Nov 13, 2023, 9:54AM
Seeking Alpha - Nov 13, 2023, 8:43AM
TipRanks - Nov 11, 2023, 4:35PM
TipRanks - Nov 10, 2023, 6:59AM
TipRanks - Nov 5, 2023, 4:35PM
Seeking Alpha - Nov 3, 2023, 10:02AM
InvestorsObserver - Oct 31, 2023, 6:46AM
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS-1.970-1.750 0.2200
REV114.000K
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-10-30HC Wainwright & Co.Joseph PantginisMaintainsBuyBuyLowers28.005.75
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics2.42%47.3M
CPIXCumberland25%29.2M
ITRMIterum Therapeutics13.3%27.8M
SCYXSCYNEXIS1.79%63.6M
CALCCalciMedica-14.46%20.2M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

A

Other companies in VYNE Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC) and Ocuphire Pharma (NASDAQ:OCUP).

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, October 30, 2023. The analyst firm set a price target for 5.75 expecting VYNE to rise to within 12 months (a possible 69.62% upside). 7 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.39 last updated December 1, 2023 at 9:00 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.